MedPath

NEO VAGEX

NEO VAGEX

Discontinued
DIN Number

00147591

Drug Class

Human

Market Date

Dec 31, 1964

Company
HC

neolab inc

Product Information

Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.

Product Details

Health Canada regulatory and product classification information

Regulatory Identifiers
DIN Number00147591
AIG Number0302575001
Classification & Schedule
C
Drug Class
Human
S
Schedule
Prescription
A
ATC Code
G01AC52 CLIOQUINOL, COMBINATIONS
Product Specifications
Dosage FormTablet
Route of AdministrationVaginal
AHFS Classification84:04.92
Health Canada Classification

ACTIVE INGREDIENTS (3)

ACETARSOLActive
Strength: 100 MG
Monograph: ACETARSOL
BENZALKONIUM CHLORIDEActive
Strength: 2 MG
Monograph: BENZALKONIUM CHLORIDE
CLIOQUINOLActive
Strength: 50 MG
Monograph: CLIOQUINOL

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.